Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study)

J Antimicrob Chemother. 2021 May 12;76(6):1646-1648. doi: 10.1093/jac/dkab060.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • APACHE
  • Anti-HIV Agents* / therapeutic use
  • CD4-Positive T-Lymphocytes
  • HIV Antibodies
  • HIV Infections* / drug therapy
  • HIV-1*
  • Humans
  • Viral Load
  • Virus Latency

Substances

  • Anti-HIV Agents
  • HIV Antibodies

Associated data

  • ClinicalTrials.gov/NCT03198325